Leadoptik
Precision optics for early lung cancer detection.
San Jose, United States · Founded 2022
- Headquarters
- San Jose, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2B
- Website
- leadoptik.com
- Last Round
- Series ASep 2025
- Rounds
- 2
About
LeadOptik (LEADOPTIK) is a medical device company developing precision optics technology for tissue intelligence and lung cancer detection. Its flagship Last Inch Assessment (LIA) technology provides real-time microstructure imaging to guide bronchoscopic biopsies, helping clinicians confirm needle placement in small lesions. The company received FDA clearance in January 2026 and is headquartered in San Jose, California.
Summary
Leadoptik is a Healthcare company based in San Jose, United States, founded in 2022. Its most recent funding was a Series A round in Sep 2025. Investors include SCP Ventures, SOSV and HAX.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sep 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Largest private manufacturer and distributor of medical-surgical products serving healthcare prov...
Healthcare cost management company providing data analytics and network-based payment solutions t...
American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe